- Human（1）
No data
- Fc Tag（1）
No data
- HEK293（1）
No data
- Unconjugated（1）
No data
- RUO（1）
No data
- No（1）
No data
- 100ug/$285.00
- 1mg (500ug X 2)/$1815.00
No data
| Molecule | Cat. No. | Product Name | Species | Host | Structure | Purity | Activity | Size&Price |
|---|---|---|---|---|---|---|---|---|
| IL-1 RI | Human IL-1 RI Protein, Fc Tag (MALS verified) |  Human | HEK293 |  | MALSSDS-PAGE | $285.00 100ug |
| English Name | Research Code | Highest Development Stage | Company | Indication | Clinical Trial |
|---|---|---|---|---|---|
| ACT-01 | ACT-01; OCS-05; BN-201; G-79 | Phase 2 Clinical | Promius Pharma | Keratosis, Actinic; Optic Neuritis; Demyelinating Diseases | Details |
| Xentuzumab | BI-836845 | Phase 2 Clinical | C.H. Boehringer Sohn Ag & Co. Kg | Neoplasms; Prostatic Neoplasms, Castration-Resistant; Breast Neoplasms; Prostatic Neoplasms; Carcinoma, Non-Small-Cell Lung | Details |
| Dusigitumab | MEDI-573 | Phase 2 Clinical | Medimmune Llc | Solid tumours; Neoplasms; Breast Neoplasms; Carcinoma, Hepatocellular | Details |
